Tradename: PAXIL CR

Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects
Status: Completed Condition: Depressive Disorder; Healthy Volunteer

Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome
Status: Completed Condition: Fibromyalgia Syndrome

Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early Improvement
Status: Recruiting Condition: Major Depression

Paxil CR Bioequivalence Study Brazil - Fed Administration
Status: Completed Condition: Depressive Disorder; Healthy Volunteers

Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)
Status: Completed Condition: Major Depressive Disorder; Depressive Disorder

PAXIL CR Bioequivalence Study
Status: Completed Condition: Two Single Doses of Controlled Release Paroxetine Given 14 Days Apart; Depressive Disorder; Healthy Volunteer

Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)
Status: Completed Condition: Depressive Disorder; Major Depressive Disorder (MDD)

A Local Register Study For Major Depression Of Paroxetine Controlled Release
Status: Completed Condition: Depressive Disorder, Major; Major Depressive Disorder (MDD)

Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CRâ„¢ Tablets 25 mg
Status: Completed Condition: Healthy

Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CRâ„¢ Tablets 25 mg
Status: Completed Condition: Healthy